Brain-immune interactions and disease susceptibility (Q36026815)

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Cytokines and sickness behavior: implications for cancer care and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

21 January 2018

The inflammatory reflex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Adaptive immunity in mice lacking the beta(2)-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Further substantiation of a significant role for the sympathetic nervous system in inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

The importance of being receptive

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Sympathetic nervous system regulation of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Selective regulation of T-cell development and function by calcitonin gene-related peptide in thymus and spleen. An example of differential regional regulation of immunity by the neuroendocrine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Cutting Edge: Vasoactive Intestinal Peptide Acts as a Potent Suppressor of Inflammation In Vivo byTrans-Deactivating Chemokine Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Elaborate interactions between the immune and nervous systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

A unified nomenclature system for the nuclear receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Enhancing versus suppressive effects of stress hormones on skin immune function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Neural immune pathways and their connection to inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Molecular mechanisms of glucocorticosteroid actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Glucocorticoids and immune function: physiological relevance and pathogenic potential of hormonal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

The possible mediation by cyclic AMP of the stimulation of thymocyte proliferation by vasopressin and the inhibition of this mitogenic action by thyrocalcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Hypothalamic-pituitary-thyroid axis and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Immunomodulation of peripheral lymphocytes by hormones of the hypothalamus-pituitary-thyroid axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

The roles of steroid hormones in arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Different roles for androgens and estrogens in the susceptibility to autoimmune rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Hypothalamic-pituitary-adrenocortical and gonadal functions in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Dehydroepiandrosterone sulfate improves memory in aging mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Sigma (sigma1) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Dehydroepiandrosterone is an anxiolytic in mice on the plus maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Dehydroepiandrosterone and its sulfated derivative reduce neuronal death and enhance astrocytic differentiation in brain cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Role of oestrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effects on thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Mode of action of interleukin-1 in suppression of pituitary LH release in castrated male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Pulsatile rhythms of adrenocorticotropin (ACTH) and cortisol in women with endogenous depression: evidence for increased ACTH pulse frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Symptom profiles of biological markers in depression: a multivariate study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

The corticosteroid receptor hypothesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Cortisol secretion in endogenous depression. I. Basal plasma levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Cortisol secretion in endogenous depression. II. Time-related functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Pituitary-adrenal axis rhythm disturbances in psychiatric depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Pituitary size in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Adrenal gland enlargement in major depression. A computed tomographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

The role of corticotropin-releasing factor in the pathogenesis of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Residual symptoms in depression: an emerging therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

DST Studies in Psychotic Depression: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Hypothalamic-pituitary-adrenal axis function in patients with chronic depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Faulty cortisol/serotonin interplay. Psychopathological and biological characterisation of a new, hypothetical depression subtype (SeCA depression)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Levels and variability of daily life cortisol secretion in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Bio-social origins of depression in the community. Interactions between social adversity, cortisol and serotonin neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

The relevance of the in- versus outpatient status for studies on HPA-axis in depression: spontaneous hypercortisolism is a feature of major depressed inpatients and not of major depression per se.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Plasma sialyltransferase levels in psychiatric disorders as a possible indicator of HPA axis function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Molecular mechanisms of glucocorticoid receptor sensitivity and relevance to affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Altered glucocorticoid immunoregulation in treatment resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Vasoconstrictor response to topical beclomethasone in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Glucocorticoid resistant syndromes--molecular basis and clinical presentations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Low yield of thyroid-stimulating hormone testing in elderly patients with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

The relation between thyroid function and depression: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

An evaluation of basal hypothalamic-pituitary-thyroid axis function in depression: results of a large-scaled and controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

The hypothalamic-pituitary-thyroid axis in psychiatric patients and healthy subjects: Parts 1-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Hypothalamic-pituitary-thyroid-axis function in treatment resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Thyroid indices and response to fluoxetine and nortriptyline in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Disturbances in hypothalamo pituitary adrenal and thyroid axis identify different sleep EEG patterns in major depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Thyroid function in clinical subtypes of major depression: an exploratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

The link between thyroid autoimmunity (antithyroid peroxidase autoantibodies) with anxiety and mood disorders in the community: a field of interest for public health in the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

The role of thyroid hormones in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Neuroendocrine-immune disturbances in animal models with spontaneous autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Disturbed immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in murine lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Disturbed immuno-endocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Animal models of neuroimmune interactions in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Mechanisms of Corticosteroid Resistance in Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

The neuroendocrine axis in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Altered responsiveness of the hypothalamus-pituitary-adrenal axis and the sympathetic adrenomedullary system to stress in patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Endocrine and immune responses to stress in chronic inflammatory skin disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Attenuated Free Cortisol Response to Psychosocial Stress in Children with Atopic Dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

The hypothalamic-pituitary-adrenal axis in the pathogenesis of rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Neuroendocrine correlates of chronic fatigue syndrome: a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Uncoupling of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in inflammatory bowel disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Review on the influence of stress on immune mediators, neuropeptides and hormones with relevance for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

The HPA axis and the genesis of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

The neuroendocrinology of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Glucocorticoid receptor variants: clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Anthrax lethal factor represses glucocorticoid and progesterone receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Hypothalamic-pituitary-adrenal axis regulation of inflammation in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Glucocorticoid receptors in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Glucocorticoid receptor downregulation in early diagnosed rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Involvement of the glucocorticoid receptor in the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

The immune suppressive effect of dexamethasone in rheumatoid arthritis is accompanied by upregulation of interleukin 10 and by differential changes in interferon gamma and interleukin 4 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

The brain is an important target of adrenal steroid actions. A comparison of synthetic and natural steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Psychoneuroimmunology of depression: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Low free testosterone levels in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Thyroid function and immune profile in rheumatoid arthritis. A controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Thyroid dysfunction in rheumatoid arthritis: a controlled prospective survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Serum interleukin-6 and thyroid hormones in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Psychological disorders in rheumatoid arthritis: a growing consensus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Rheumatoid arthritis and schizophrenia: a negative association at a dimensional level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

The relationship of depression and stressors to immunological assays: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Depression and immunity: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Depression: a major, unrecognized risk factor for osteoporosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Direct stimulation of bone resorption by thyroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Spontaneous release of interleukin 1 beta from human blood monocytes in thyrotoxic osteodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Increased serum interleukin-6 concentration in patients with subacute thyroiditis: relationship with concomitant changes in serum T4-binding globulin concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Thyroid hormone stimulates alkaline phosphatase activity in cultured rat osteoblastic cells (ROS 17/2.8) through 3,5,3'-triiodo-L-thyronine nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Leptin regulates bone formation via the sympathetic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Differential effects of psychological and immunological challenge on the hypothalamo-pituitary-adrenal axis function in adjuvant-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Arthritis-susceptible Lewis rats fail to emerge from the stress hyporesponsive period

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Intracerebroventricular Transplantation of Embryonic Neuronal Tissue from Inflammatory Resistant into Inflammatory Susceptible Rats Suppresses Specific Components of Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

A mutation of the glucocorticoid receptor gene in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

The phase-shift mutation in the glucocorticoid receptor gene: potential etiologic significance of neuroendocrine mechanisms in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Diagnosis and management of steroid-resistant asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Inhaled glucocorticoids for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Routine Screening of Thyroid Function in Patients Hospitalized for Major Depression or Dysthymia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

A study of the role of corticosterone as a mediator in exercise-induced stimulation of murine macrophage phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Association of Depression and Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Bidirectional heterologous desensitization of opioid and chemokine receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Anti-inflammatory actions of glucocorticoids: molecular mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

How the glucocorticoids suppress immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Enhancement of rat splenic lymphocyte mitogenesis after short term preexposure to corticosteroids in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Induction of cytokine receptors by glucocorticoids: functional and pathological significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Effects of Short and Long Duration Hypothyroidism and Hyperthyroidism on the Plasma Adrenocorticotropin and Corticosterone Responses to Ovine Corticotropin-Releasing Hormone in Rats*

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Neuroactive steroids regulate astroglia morphology in hippocampal cultures from adult rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Corticotropin-releasing factor decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophysial-portal circulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Response to dexamethasone and subtype of depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Neuroendocrine aspects of primary endogenous depression. V. Serum prolactin measures in patients and matched control subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Cortisol production in depressive illness. A clinical and biochemical clarification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Hypothalamic-pituitary-adrenal axis and suicide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Assessment of adrenal gland volume by computed tomography in depressed patients and healthy volunteers: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

The oCRH stimulation test before and after clinical recovery from depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

The dexamethasone suppression test in patients with mood disorders.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Failure to normalize the dexamethasone suppression test: association with length of illness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Glucocorticoid receptor binding in three different cell types in major depressive disorder: lack of evidence of receptor binding defect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

The Proinflammatory Cytokine, Interleukin-1α, Reduces Glucocorticoid Receptor Translocation and Function1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Altered serum levels of thyroxine, triiodothyronines and diiodothyronines in endogenous depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Hormones of the hypothalamic-pituitary-thyroid axis: a psychoneuroendocrine perspective

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Glucocorticoids stimulate thyrotropin-releasing hormone gene expression in cultured hypothalamic neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

The role of the hypothalamic-pituitary-adrenal axis in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Abnormal hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis. Effects of nonsteroidal antiinflammatory drugs and water immersion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Circadian variation in disease activity in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Role of pro-inflammatory cytokines in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Relationships between serum 17 beta-oestradiol and anticardiolipin antibody concentrations in female patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Thyroid involvement in chronic inflammatory rheumatological disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Factors associated with the appearance of psychiatric symptoms in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Glucocorticoid-induced osteoporosis: prevention and treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Secondary osteoporosis. Diagnostic considerations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Mechanism of the regulation of the 1α,25-dihydroxyvitamin D3 receptor in the rat jejunum by glucocorticoids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Serum levels of interleukin 6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021

TSH Is a Negative Regulator of Skeletal Remodeling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001643

7 January 2021